Centrophenoxine - Table 4: Benefits
Category | Benefit type | Magnitude | Likelihood | Duration | Importance to patient | Summary | Weight | Score | Uncertainty | Weighted score | |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Dementia & cognitive decline | ↑ clinical improvement/stabilization in dementia & cognitive decline | 1 | 2 | 1 | 2 | 6 | 1.5 | +1 | 0.75 | |
2 | Dementia & cognitive decline | ↑ ADL in dementia & cognitive decline | 1
| 1
| 1
| 2
| 5 | 1.25 | +1 | 0 | |
3 | Dementia & cognitive decline | ↑ clinical improvement in corpus callosum degeneration | 1 | 2 | 1 | 3 | 7 | 1.75 | +1 | 2 Open-label: Dai & Li, 2012 | 0.5 |
4 | Dementia & cognitive decline | ↓ neurological deficit in VaD | 1 | 2 | 1 | 3 | 7 | 1.75 | +1 | 1.25 | |
5 | Dementia & cognitive decline | ↑ clinical improvement in VaD | 1 | 2 | 1 | 3 | 7 | 1.75 | +1 | 1.25 | |
6 | General | ↑ CBF | 1 | 3 | 1 | 2 | 7 | 1.75 | +1 | 2 Comparative/Open-label: | 1 |
7 | General | ↑ clinical improvement in chronic cerebrovascular disease | 1 | 1 | 1
| 1
| 4 | 1 | +1 | 0 | |
8 | Metabolism & biochemistry | ↓ age-related intracellular water loss | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 1 RCT: Fülöp et al., 1990 | 0.75 |
9 | Metabolism & biochemistry | ↑ blood oxygen saturation & consumption | 1 | 1 | 1 | 1 | 4 | 1 | +1 | ; | 0 |
10 | Metabolism & biochemistry | ↓ fasting glucose levels | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 2 Open-label: | 0 |
11 | Metabolism & biochemistry | ↑ normalization of blood glucose dynamics | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 2 Comparative: Stoica et al., 1974 | 0 |
12 | ↑ oxidative stress mitigation | 2 | 1 | 1 | 1 | 5 | 1.25 | +1 | 1 RCT: Zheng et al., 2011 2 Comparative: Tang & Dong, 2018 | 1.25 | |
13 | Metabolism & biochemistry | ↑ energy | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 2 Open-label: | 0 |
14 | Metabolism & biochemistry | ↑ biomarkers in cerebrovascular disease | 2
| 1 | 1 | 2 | 6 | 1.5 | +1 | 1.5 | |
15 | Movement disorders | ↑ reflexes in cerebral palsy | 1 | 1 | 1 | 2 | 5 | 1.25 | +1 | 2 Open-label: Bradna, 1967 | 0 |
16 | Movement disorders | ↓ involuntary movements in tardive dyskinesia | 2 | 2 | 2 | 2 | 8 | 2 | +1 | 2 Open-label: | 0 |
17 | Movement disorders | ↓ ALS symptoms | 1 | 1 | 1 | 2 | 5 | 1.25 | +1 | 2 Comparative: Sercl & Kovarik, 1963 | 0 |
18 | Musculoskeletal | ↑ bone mineral density | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 2 Comparative: Li et al., 2019 | 0 |
19 | Musculoskeletal | ↓ shoulder stiffness | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 2 Open-label: Herrschaft, 1992 Conflict: | 0 |
20 | Neurological symptoms | ↓ ischemia-induced orthostatic hypotension & abnormal catecholamine response | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 2 Open-label: Stoica & Enulescu, 1991 | 0 |
21 | Neurological symptoms | ↓ dizziness | 1 | 2 | 1 | 2 | 6 | 1.5 | +1 | 1 RCT: | 1.5 |
22 | Neurological symptoms | ↓ headache | 1 | 2 | 1 | 2 | 6 | 1.5 | +1 | 2 Open-label: Lin, 2001; Conflict: | 0 |
23 | Neurological symptoms | ↑ HRV in ACI | 1 | 1 | 1 | 2 | 5 | 1.25 | +1 | 0 | |
24 | Neurological symptoms | ↓ vertigo | 1 | 1 | 1 | 2 | 5 | 1.25 | +1 | 0 | |
25 | Neurological symptoms | ↓ visually-triggered gaze saccade latency in post-traumatic cervical syndrome | 2 | 2 | 1 | 1 | 6 | 1.5 | +1 | 0 | |
26 | Neurological symptoms | ↑ clinical improvement in cortical blindness | 1 | 1 | 1 | 2 | 5 | 1.25 | +1 | 0 | |
27 | Perinatal & pediatric | ↑ long-term memory & learning in children | 1 | 1 | 1 | 2 | 5 | 1.25 | +1 | 0 | |
28 | Perinatal & pediatric | ↑ general cognition & mental performance in children | 1 | 2 | 1 | 2 | 6 | 1.5 | +1 | 0 | |
29 | Perinatal & pediatric | ↑ behavior & mood in children | 1 | 1 | 1 | 1 | 4 | 1 | +1 | 0 | |
30 | Perinatal & pediatric | ↑ clinical improvement in | 1 | 2 | 2 | 3 | 8 | 2 | +1 | 1 RCT: Guo, 2013; Pu & Liu, 2008; Xiang & Wang, 2005; Wang, 2011; Fang et al., 2010; Hui & Zhang, 2022 2 Comparative: | 1.5 |
31 | Perinatal & pediatric | ↑ condition of the newborn in SGA fetuses | 2 | 2 | 2 |